Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects (original) (raw)

• Greenamyre JT, Porter RHP . Anatomy and physiology of glutamate in the CNS Neurology 1994 44 (Suppl 8): S7–S13
  Google Scholar
• Farber NB, Newcomer JW, Olney JW . The glutamate synapse in neuropsychiatric disorders: focus on schizophrenia and Alzheimer's disease Prog Brain Res 1998 116: 421–437
  Article CAS Google Scholar
• Cooper JR . Amino acid transmitters. In: The Biochemical Basis of Neuropharmacology Oxford University Press: New York 1996 pp 116–193
• Fonnum F . Glutamate: a neurotransmitter in mammalian brain J Neurochem 1984 42: 1–11
  Article CAS Google Scholar
• Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy Arch Gen Psychiatry 1997 54: 959–965
  Article CAS Google Scholar
• Glantz LA, Lewis DA . Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 2000 57: 65–73
  Article CAS Google Scholar
• Selemon LD, Rajkowska G, Goldman-Rakic PS . Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional stereologic counting method J Comp Neurol 1998 392: 402–412
  Article CAS Google Scholar
• Lewis DA . Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia Neurophychopharmacology 1997 16: 385–398
  Article CAS Google Scholar
• Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WST . Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’ Mol Psychiatry 1999 4: 39–45
  Article CAS Google Scholar
• Selemon LD, Goldman-Rakic PS . The reduced neuropil hypothesis: a circuit based model of schizophrenia Biol Psychiatry 1999 45: 17–25
  Article CAS Google Scholar
• Weinberger DR, Berman KF, Zec RF . Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I Regional cerebral blood flow (rCBF) evidence Arch Gen Psychiatry 1986 45: 609–615
  Article Google Scholar
• Carlsson A, Hansson LO, Waters N, Carlsson ML . A glutamatergic deficiency model of schizophrenia Br J Psychiatry 1999 174 (Suppl 37): 2–6
  Article Google Scholar
• Bartha R, Williamson PC, Drost DJ, Malla A, Carr TJ, Cortese L et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy Arch Gen Psychiatry 1997 54: 959–965
  Article CAS Google Scholar
• Moghaddam B, Adams BW, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex J Neuroscience 1997 17: 2921–2927
  Article CAS Google Scholar
• Moghaddam B, Adams BW . Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 1998 281: 1349–1352
  Article CAS Google Scholar
• Javitt DC, Zukin SR . Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 1991 148: 1301–1308
  Article CAS Google Scholar
• Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers Neuropsychopharmacology 1996 14: 301–307
  Article CAS Google Scholar
• Newcomer JW, Farber NB, Jevtovic-Tedorovic V, Selke G, Melson AK, Hershey T et al. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis Neuropsychopharmacology 1999 20: 106–118
  Article CAS Google Scholar
• Lahti AC, Koffel B, LaPorte D, Tamminga CA . Subanesthetic doses of ketamine stimulate psychosis in schizophrenia Neuropsychopharmacology 1995 13: 9–19
  Article CAS Google Scholar
• Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics Neuropsychopharmacology 1997 17: 141–150
  Article CAS Google Scholar
• Shroeder U, Schroeder H, Schwegler H, Sable BA . Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory Br J Pharmacol 2000 130: 33–40
  Article Google Scholar
• Verma A, Moghaddam B . The role of excitatory amino acids in prefrontal cortex function as assessed by spatial delayed alternation performance in rats: modulation by dopamine J Neurosci 1996 16: 373–379
  Article CAS Google Scholar
• Parada-Turska J, Turski W . Excitatory amino acid antagonists and memory: effect of drugs acting at _N_-methyl-D-aspartate receptors in learning and memory tasks Neuropharmacology 1990 29: 1111–1116
  Article CAS Google Scholar
• Krystal J, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans Psychopharmacol (Berl) 1999 145: 193–204
  Article CAS Google Scholar
• Wang JK, Thukral V . Presynaptic NMDA receptors display physiological characteristics of homomeric complexes of NRI subunits that contain the exon 5 insert in the N-terminal domain J Neurochem 1996 66: 865–868
  Article CAS Google Scholar
• Huntly GW, Vickers JC, Morrison JH . Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organization features related to cortical circuitry, function and disease Trends Neurosci 1994 17: 536–542
  Article Google Scholar
• Smirnova T, Stinnakre J, Mallet J . Characterization of a presynaptic glutamate receptor Science 1993 262: 430–433
  Article CAS Google Scholar
• Richardson-Burns SM, Haroutunian V, Davis KL, Watson SJ, Meador-Woodruff JH . Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus Biol Psychiatry 2000 47: 22–28
  Article CAS Google Scholar
• Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC . Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia Brain Res Mol Brain Res 1998 56: 207–217
  Article CAS Google Scholar
• Pin JP, Duvoisin R . The metabotropic glutamate receptors: structure and functions Neuropharmacology 1995 34: 1–26
  Article CAS Google Scholar
• Salt TE, Eaton SA . Function of metabotropic excitatory amino acid receptors in sensory transmission in the thalamus: studies with novel phenyglycine antagonists Neurochemistry 1994 24: 451–458
  Article CAS Google Scholar
• Anwyl R . Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res Rev 1999 29: 83–120
  Article CAS Google Scholar
• Holscher C, Gigg J, O'Mara S . Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning, and neurotoxicity Neurosci Biobehav Rev 1999 23: 399–410
  Article CAS Google Scholar
• Conn PJ, Pin JP . Pharmacology and functions of metabotropic glutamate receptors Ann Rev Pharmacol Toxicol 1997 37: 205–237
  Article CAS Google Scholar
• Pellicciari R, Costantino G . Metabotropic G-protein-coupled glutamate receptors as therapeutic targets Curr Opin Chemical Biol 1999 3: 433–440
  Article CAS Google Scholar
• Schoepp DD, Jane DD, Monn JA . Pharmacological agents acting at subtypes of metabotropic glutamate receptors Neuropharmacology 1999 38: 1431–1476
  Article CAS Google Scholar
• Schoepp DD, Johnson BG, Monn JA . Inhibition of cyclic AMP formation by a selective metabotropic glutamate receptor agonist J Neurochem 1992 58: 1184–1186
  Article CAS Google Scholar
• Chavis P, Shinozaki H, Bockaert J, Fagni L . The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells J Neurosci 1994 14: 7067–7076
  Article CAS Google Scholar
• Battaglia G, Bruno V, Ngomba RT, Di Grezia R, Copani A, Nicoletti F . Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death Eur J Pharmacol 1998 256: 271–274
  Article Google Scholar
• Bond A, O'Neill MJ, Hicks CA, Monn JA, Lodge D . Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischemia Neuroreport 1998 9: 1191–1193
  Article CAS Google Scholar
• Petralia RS, Wang YX, Niedzielski S, Wenthold RJ . The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 1996 71: 949–976
  Article CAS Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn American Psychiatric Press: Washington, DC 1994
• Rajkowska G, Goldman-Rakic PS . Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the talairach coordinate system Cereb Cortex 1995 5: 323–337
  Article CAS Google Scholar
• Iniguez C, Gayoso MJ, Carreres J . A versatile and simple method for staining nervous tissues using Giemsa dye J Neurosci Meth 1985 13: 77–86
  Article CAS Google Scholar
• Laemmli UK . Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 1979 227: 680–685
  Article Google Scholar
• Testa CM, Friberg IK, Weiss SW, Standaert DG . Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia J Comp Neurol 1998 390: 5–19
  Article CAS Google Scholar
• Yung KK . Localization of glutamate receptors in dorsal horn of rat spinal cord Neuroreport 1998 9: 1639–1644
  Article CAS Google Scholar
• Daly DA, Moghaddam B . Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats Neurosci Lett 1993 152: 61–64
  Article CAS Google Scholar
• Yamamoto BK, Cooperman MA . Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations J Neurosci 1994 14: 4159–4166
  Article CAS Google Scholar
• Ossowska K, Pietraszek M, Wardas J, Nowak G, Zajaczkowski W, Wolfarth S et al. The role of glutamate receptors in antipsychotic drug action Amino Acids 2000 19: 87–94
  Article CAS Google Scholar
• Cartmell J, Monn JA, Schoepp DD . The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing Eur J Pharmacol 2000 400: 221–224
  Article CAS Google Scholar
• Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD . The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat J Neurochem 2000 75: 1147–1154
  Article CAS Google Scholar